Stifel Raises Alignment Healthcare Price Target Amid Strong Revenue Growth Stifel has increased its price target for Alignment Healthcare to $23, up from $18, maintaining a Buy rating. The move follows the CMS's Final Rate Notice, which exceeded expectations and is seen as a positive for the company. Alignment Healthcare's stock has surged 271% over the past year, reflecting robust momentum.12